Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.
2.
3.

Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics.

Zhang XY, Zhou DF, Qi LY, Chen S, Cao LY, Chen DC, Xiu MH, Wang F, Wu GY, Lu L, Kosten TA, Kosten TR.

Psychopharmacology (Berl). 2009 May;204(1):177-84. doi: 10.1007/s00213-008-1447-6. Epub 2009 Jan 13.

PMID:
19139851
4.
5.

Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

Psychopharmacology (Berl). 2005 Feb;178(1):35-40. Epub 2004 Jul 31.

PMID:
15289996
6.

Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

Int Clin Psychopharmacol. 2001 Nov;16(6):325-30.

PMID:
11712620
7.

The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial.

Zhang XY, Zhou DF, Cao LY, Wu GY.

Psychopharmacology (Berl). 2006 Sep;188(1):12-7. Epub 2006 Aug 12.

PMID:
16906395
8.

Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia.

Zhang XY, Zhou DF, Yuan CL, Zhang PY, Wu GY, Shen YC.

Psychiatry Res. 2002 Apr 15;109(3):297-302.

PMID:
11959366
9.

Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia.

Tan Y, Li Y, Tan S, Wang Z, Yang FD, Cao B, Zunta-Soares GB, Soares JC, Zhang XY.

Schizophr Res. 2015 Dec;169(1-3):16-21. doi: 10.1016/j.schres.2015.10.038. Epub 2015 Nov 6.

PMID:
26549630
10.

Rapid onset of therapeutic effect of risperidone versus haloperidol in a double-blind randomized trial.

Rabinowitz J, Hornik T, Davidson M.

J Clin Psychiatry. 2001 May;62(5):343-6.

PMID:
11411815
11.

Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.

Zhang XY, Zhou DF, Zhang PY, Wu GY, Cao LY, Shen YC.

Schizophr Res. 2002 Oct 1;57(2-3):247-58. Erratum in: Schizophr Res. 2003 Mar 1;60(1):101..

PMID:
12223256
12.

Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia.

Zhang XY, Zhou DF, Shen YC, Zhang PY, Zhang WF, Liang J, Chen DC, Xiu MH, Kosten TA, Kosten TR.

Neuropharmacology. 2012 Apr;62(5-6):1928-34. doi: 10.1016/j.neuropharm.2011.12.014. Epub 2011 Dec 30.

PMID:
22227558
13.

The effect of risperidone treatment on superoxide dismutase in schizophrenia.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

J Clin Psychopharmacol. 2003 Apr;23(2):128-31.

PMID:
12640213
14.

Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.

Citrome L, Meng X, Hochfeld M, Stahl SM.

Hum Psychopharmacol. 2012 Jan;27(1):24-32. doi: 10.1002/hup.1254. Epub 2011 Dec 7.

PMID:
22161738
15.

The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

Marder SR, Davis JM, Chouinard G.

J Clin Psychiatry. 1997 Dec;58(12):538-46. Erratum in: J Clin Psychiatry 1998 Apr;59(4):200.

PMID:
9448657
16.

Adverse effects of risperidone and haloperidol treatment in schizophrenia.

Yen YC, Lung FW, Chong MY.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):285-90.

PMID:
14751424
17.

[Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia].

Lü LX, Guo SQ, Chen W, Li Q, Cheng J, Guo JH.

Di Yi Jun Yi Da Xue Xue Bao. 2004 Nov;24(11):1251-4. Chinese.

18.

Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel RR, Kleindienst N, Müller N, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):360-70. Epub 2007 Jul 14.

PMID:
17629731
19.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
20.

Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients.

Lee SM, Chou YH, Li MH, Wan FJ, Yen MH.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1101-7. Epub 2007 Apr 1.

PMID:
17475386

Supplemental Content

Support Center